SIOG 2024 Advanced Course in Geriatric Oncology

The SIOG Advanced Course in Geriatric Oncology is designed for professionals who want to stay at the peak of their expertise. The course a training programme led by international experts in the field of geriatrics and oncology designed to provide specific skills in assessment, care pathways and therapeutic choices for older patients with cancer. It […]

I.N.N.O.VA.TE- International Neoadjuvant Immunotherapy Across Cancers

Immune checkpoint blockade (ICB) has revolutionized outcomes for patients with advanced cancers. Building upon this marked success, evaluation of ICB in patients with surgically resectable disease has been pursued across multiple cancer types. In addition to an improvement in operability, improving the anti-tumor immune response, as measured by pathologic response, neoadjuvant immunotherapy continues to demonstrate […]

ENETS-NANETS webinar: New insights, directions & signals

The objective of this webinar is to highlight recent trials with significant implications for neuroendocrine tumor (NET) science and research, as presented at the 2023 and 2024 annual conferences of ENETS and NANETS. The webinar will feature mature trials addressing key aspects of digestion and practical implementation of findings in clinical practice, alongside discussions on […]

Multidisciplinary management of head and neck oncology

The course aims to be interactive through integration of multidisciplinary lectures and more focused workshops. The faculty includes renowned European experts involved in the multidisciplinary treatment of head and neck cancer.

30th EMMA (European Multiple Myeloma Academy)/Post-ASCO (American Society of Clinical Oncology) / Post-EHA (European Hematology Association) 2024

2-day educational event, as an in-person meeting. Full immersion, clinically oriented, multidisciplinary meeting offers plenary lectures: myeloma biology, new tools for prognostication and monitoring in Multiple Myeloma, front line treatment for young patients with MM, front line treatment for elderly patients with MM, immunotherapy, relapsed/ refractory patients, other malignant gammopathies apart from multiple myeloma, etc. […]